GL1X · GenesisL1 explorer

UniProt Q95460

Major histocompatibility complex class I-related gene protein (Q95460)

Major histocompatibility complex class I-related gene protein (UniProt Q95460): 85 experimental structures and 1 predicted model on GenesisL1, 27 ligands bound, 82 pockets. Binding sites, druggability and experiment against…

UniProt
Q95460
Protein
Major histocompatibility complex class I-related gene protein
Experimental structures
85
Predicted models
1
Ligands
27
Pockets
82 · 6 records with a druggable one

Structures

86 records of Q95460 in the MolNFT archive: 85 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
4GUPStructure of MHC-class I related molecule MR1x-ray diffractionA, C——
4GUPStructure of MHC-class I related molecule MR1x-ray diffractionA, C——
4L4TStructure of human MAIT TCR in complex with human MR1-6-FPx-ray diffractionA, C——
4L4TStructure of human mait TCR in complex with human MR1-6-fpx-ray diffractionA, C——
4L4VStructure of human MAIT TCR in complex with human MR1-RL-6-Me-7-OHx-ray diffractionA, C——
4L4VStructure of human mait TCR in complex with human MR1-rl-6-me-7-ohx-ray diffractionA, C——
4LCWThe structure of human MAIT TCR in complex with MR1-K43A-RL-6-Me-7OHx-ray diffractionA, C——
4LCWThe structure of human mait TCR in complex with MR1-K43A-rl-6-me-7OHx-ray diffractionA, C——
4NQCCrystal structure of TCR-MR1 ternary complex and covalently bound…x-ray diffractionA, C——
4NQCCrystal structure of TCR-MR1 ternary complex and covalently bound 5…x-ray diffractionA, C——
4NQDCrystal structure of TCR-MR1 ternary complex and non-covalently bound…x-ray diffractionA, C——
4NQDCrystal structure of TCR-MR1 ternary complex and non-covalently bound…x-ray diffractionA, C——
4NQECrystal structure of TCR-MR1 ternary complex bound to…x-ray diffractionA, C——
4NQECrystal structure of TCR-MR1 ternary complex bound to 5-(2…x-ray diffractionA, C——
4PJ5Structure of human MR1-Ac-6-FP in complex with human MAIT TRBV6-1 TCRx-ray diffractionA, C——
4PJ5Structure of human MR1-ac-6-fp in complex with human mait TRBV6-1 TCRx-ray diffractionA, C——
4PJ7Structure of human MR1-5-OP-RU in complex with human MAIT TRBV6-4 TCRx-ray diffractionA, C——
4PJ7Structure of human MR1-5-op-ru in complex with human mait TRBV6-4 TCRx-ray diffractionA, C——
4PJ8Structure of human MR1-5-OP-RU in complex with human MAIT TRBV20 TCRx-ray diffractionA——
4PJ8Structure of human MR1-5-op-ru in complex with human mait TRBV20 TCRx-ray diffractionA——
4PJ9Structure of human MR1-5-OP-RU in complex with human MAIT TRAJ20 TCRx-ray diffractionA——
4PJ9Structure of human MR1-5-op-ru in complex with human mait TRAJ20 TCRx-ray diffractionA——
4PJAStructure of human MR1-5-OP-RU in complex with human MAIT B-B10 TCRx-ray diffractionA, C——
4PJAStructure of human MR1-5-op-ru in complex with human mait B-B10 TCRx-ray diffractionA, C——
4PJBStructure of human MR1-5-OP-RU in complex with human MAIT B-F3-C1 TCRx-ray diffractionA, C——
4PJBStructure of human MR1-5-op-ru in complex with human mait B-F3-C1 TCRx-ray diffractionA, C——
4PJCStructure of human MR1-5-OP-RU in complex with human MAIT C-A11 TCRx-ray diffractionA, C——
4PJCStructure of human MR1-5-op-ru in complex with human mait C-A11 TCRx-ray diffractionA, C——
4PJDStructure of human MR1-5-OP-RU in complex with human MAIT C-C10 TCRx-ray diffractionA, C——
4PJDStructure of human MR1-5-op-ru in complex with human mait C-C10 TCRx-ray diffractionA, C——
4PJEStructure of human MR1-Ac-6-FP in complex with human MAIT B-B10 TCRx-ray diffractionA, C——
4PJEStructure of human MR1-ac-6-fp in complex with human mait B-B10 TCRx-ray diffractionA, C——
4PJFStructure of human MR1-Ac-6-FP in complex with human MAIT B-C10 TCRx-ray diffractionA, C——
4PJFStructure of human MR1-ac-6-fp in complex with human mait B-C10 TCRx-ray diffractionA, C——
4PJGStructure of human MR1-Ac-6-FP in complex with human MAIT B-F3-C1 TCRx-ray diffractionA, C——
4PJGStructure of human MR1-ac-6-fp in complex with human mait B-F3-C1 TCRx-ray diffractionA, C——
4PJHStructure of human MR1-Ac-6-FP in complex with human MAIT B-G8 TCRx-ray diffractionA, C——
4PJHStructure of human MR1-ac-6-fp in complex with human mait B-G8 TCRx-ray diffractionA, C——
4PJIStructure of human MR1-Ac-6-FP in complex with human MAIT C-C10 TCRx-ray diffractionA, C——
4PJIStructure of human MR1-ac-6-fp in complex with human mait C-C10 TCRx-ray diffractionA, C——
4PJXStructure of human MR1-Ac-6-FP in complex with human MAIT C-A11 TCRx-ray diffractionA, C——
4PJXStructure of human MR1-ac-6-fp in complex with human mait C-A11 TCRx-ray diffractionA, C——
5D5MStructure of human MR1-5-OP-RU in complex with human MAIT M33.64 TCRx-ray diffractionA, C2LJ12 (best 0.78)
5D5MStructure of human MR1-5-op-ru in complex with human mait M33.64 TCRx-ray diffractionA, C——
5D7IStructure of human MR1-ac-6-fp in complex with human mait M33.64 TCRx-ray diffractionA, C——
5D7JStructure of human MR1-5-op-ru in complex with human mait M33.64(Y95ALPHAF) TCRx-ray diffractionC, E——
5D7LStructure of human MR1-5-op-ru in complex with human MAV36 TCRx-ray diffractionA, C——
5U16Structure of human MR1-2-oh-1-na in complex with human mait a-F7 TCRx-ray diffractionA, C7WO, CL—
5U17Structure of human MR1-DA-6-FP in complex with human MAIT A-F7 TCRx-ray diffractionA, C7WP—
5U17Structure of human MR1-da-6-fp in complex with human mait a-F7 TCRx-ray diffractionA, C7WP—
5U1RStructure of human MR1-diclofenac in complex with human MAIT A-F7 TCRx-ray diffractionC, ANA, DIF—
5U1RStructure of human MR1-diclofenac in complex with human mait a-F7 TCRx-ray diffractionC, ANA, DIF—
5U2VStructure of human MR1-HMB in complex with human MAIT A-F7 TCRx-ray diffractionA, C7WQ—
5U2VStructure of human MR1-hmb in complex with human mait a-F7 TCRx-ray diffractionA, C7WQ—
5U6QStructure of human MR1-3-F-sa in complex with human mait a-F7 TCRx-ray diffractionC, A7ZS—
5U72Structure of human MR1-5OH-dcf in complex with human mait a-F7 TCRx-ray diffractionA, C7ZV—
6MWRRecognition of MHC-like moleculex-ray diffractionA2LJ—
6PUCStructure of human MAIT A-F7 TCR in complex with human MR1-5-OP-RUx-ray diffractionA, CQ87, CL—
6PUCStructure of human mait a-F7 TCR in complex with human MR1-5-op-rux-ray diffractionA, CQ87, CL—
6PUDStructure of human mait a-F7 TCR in complex with human MR1-5'OH- pentyl-5-op-Ux-ray diffractionA, COYD—

26 records more on the page itself.

Ligands

  • CL · Chloride ion · in 9 records
  • 2LJ · 1-deoxy-1-({2,6-dioxo-5-[(E)-propylideneamino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol · in 6 records
  • 30W · N-(6-formyl-4-oxo-3,4-dihydropteridin-2-yl)acetamide · in 4 records
  • NA · Sodium ion · in 4 records
  • 7WP · 2,4-diaminopteridine-6-carbaldehyde · in 2 records
  • 7WQ · 2-hydroxy-5-methoxybenzaldehyde · in 2 records
  • DIF · 2-[2,6-dichlorophenyl)amino]benzeneacetic acid · in 2 records
  • Q84 · 1,2-dideoxy-1-({2,6-dioxo-5-[(E)-(2-oxopropylidene) amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-erythro-pentitol · in 2 records
  • Q87 · 1-deoxy-1-({2,6-dioxo-5-[(E)-(2-oxopropylidene)amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol · in 2 records
  • TKG · 1-[[6-(1-$l^{1}-oxidanylethyl)-4-$l^{3}-oxidanylidene-2,3,6,8~{a}-tetrahydropteridin-2-yl]-$l^{2}-azanyl]ethanone · in 2 records
  • 7WO · 2-hydroxynaphthalene-1-carbaldehyde · in 1 record
  • 7ZS · 3-methanoyl-2-oxidanyl-benzoic acid · in 1 record
  • 7ZV · 5-hydroxydiclofenac · in 1 record
  • H6N · Protocatechuic aldehyde · in 1 record
  • N18 · Methyl N-(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carbonyl)-beta-alaninate · in 1 record
  • OYD · 6-[(5-hydroxypentyl)amino]-5-[(E)-propylideneamino]pyrimidine-2,4(1H,3H)-dione · in 1 record
  • OYG · 6-methyl-5-[(1E)-3-oxobut-1-en-1-yl]pyrimidine-2,4(1H, 3H)-dione · in 1 record
  • OYV · 1,2-dideoxy-1-{2,6-dioxo-5-[(1E)-3-oxobut-1-en-1-yl]-1, 2,3,6-tetrahydropyrimidin-4-yl}-D-ribo-hexitol · in 1 record
  • OZD · 6-[(2-hydroxyethyl)amino]-5-[(E)-(2-oxopropylidene) amino]pyrimidine-2,4(1H,3H)-dione · in 1 record
  • P1J · N-(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carbonyl)-beta-alanine · in 1 record
  • PO4 · Phosphate ion · in 1 record
  • PXL · 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde · in 1 record
  • Q7J · 1,4-dideoxy-1-({2,6-dioxo-5-[(E)-(2-oxopropylidene) amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-erythro-pentitol · in 1 record
  • Q7P · 6-[(4-hydroxybutyl)amino]-5-[(E)-(2-oxopropylidene) amino]pyrimidine-2,4(1H,3H)-dione · in 1 record
  • Q7S · 6-[(3-hydroxypropyl)amino]-5-[(E)-(2-oxopropylidene) amino]pyrimidine-2,4(1H,3H)-dione · in 1 record
  • Q81 · 1,3-dideoxy-1-({2,6-dioxo-5-[(E)-(2-oxopropylidene) amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-erythro-pentitol · in 1 record
  • XIK · 3,4-dimethoxybenzaldehyde · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.